Keybanc upgrades Plexus to Overweight, sets $300 price target

Keybanc upgraded Plexus Corp to Overweight with a $300 price target, implying 18.9% upside from the Sep 21 close. The firm cites strong growth prospects in Aerospace/Defense and Industrial segments, with over 20% revenue growth expected in FY27, and disciplined capital deployment.

Original reporting
Published Sep 22, 2026, 10:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Keybanc upgrades Plexus to Overweight, sets $300 price target — source image
Decision brief

The 30-second read

$PLXSBullishMed
01

Why it matters

The upgrade could trigger re‑rating by other analysts and increase institutional interest.

02

Market read

First‑report upgrade provides actionable insight for traders focusing on mid‑cap industrial stocks.

03

What to watch

Potential supply‑chain constraints could temper revenue expansion.

Relevance 7/10Novelty 7/10Timing: today

Background

Keybanc's research note highlights strong growth prospects and disciplined capital deployment.

Company-level read

Ticker impact

$PLXSBullishHigh confidence
Context

Keybanc upgraded Plexus Corp to Overweight with a $300 price target, implying 18.9% upside.

Expected impact

Potential upside of ~15-20% as investors price in the new target.

Evidence & confidence

Upgrade and higher target are fresh primary disclosures that can drive buying pressure.

Market effects

Positive for aerospace/defense and industrial sectors as Plexus is a key supplier.

U.S. industrial equities may see modest lift.

Limited to investors tracking mid‑cap industrial stocks.

Counterpoint

Upgrade may be premature if growth forecasts miss expectations.

Key entities

  • Plexus Corp

    Industrial components manufacturer (ticker PLXS).

  • Keybanc Capital Markets

    Investment bank providing the upgrade and price target.

Related articles

$PLXSMed

What Plexus (PLXS) Said on Its Q4 Earnings Call

Plexus (PLXS) reported 36 new manufacturing wins in Q4, totaling $290M in annualized revenue. Fiscal 2026 wins reached $1.2B, with a record $4.9B pipeline. Aerospace/defense and industrial sectors drove growth, with revenue increases of 23% and 27% respectively. The company also highlighted operational efficiency improvements and a new $100M stock repurchase program for fiscal 2027.

$PLXSMedAI 9/10

Plexus Corp (PLXS) (Q4 2026) Earnings Call Highlights: Record

Plexus Corp (PLXS) reported Q4 2026 revenue of $1.43B, up 35% YoY, with fiscal 2026 revenue at $5B, up 23%. Non-GAAP operating margin was 6.7% in Q4, exceeding guidance. The company expects Q1 2027 revenue of $1.41B-$1.46B, with margin guidance of 6.0%-6.4%. Free cash flow is projected to exceed $100M in fiscal 2027, despite a negative Q1. The company's funnel of qualified manufacturing opportunities reached a record $4.9B, up 33% YoY, driven by aerospace, defense, and industrial sectors.

$PLXSHighAI 8/10

Plexus (PLXS) Q4 2026 Earnings Call Transcript

Plexus (PLXS) reported Q4 2026 revenue of $1.43B, up 35% YoY, and fiscal 2026 revenue of $5B, up 23% YoY. The company expects fiscal 2027 revenue growth in the mid to upper teens. Non-GAAP operating margin was 6.7% in Q4, up 100 bps YoY, and fiscal 2026 margin expanded 30 bps to 6.2%. Plexus introduced a new non-GAAP operating margin goal of 6.5% to 7.0% for fiscal 2027. The company secured $290M in new manufacturing wins in Q4, with a total funnel of $4.9B.

$PLXSMedAI 8/10

Why Plexus (PLXS) stock is down today

Plexus (PLXS) shares fell 9.2% after reporting Q4 revenue of $1.427B and guiding Q1 EPS below Q4. The company expects $1.41B-$1.46B in Q1 revenue and $100M+ free cash flow in fiscal 2027. PLXS is up 43.1% YTD but 28.3% below its 52-week high.